SARS-CoV-2 and COVID-19: Facing the pandemic together as citizens and cardiovascular practitioners

Minerva Cardioangiologica

Volumn 68, Issue 2, 2020, Pages 61-64

  Biondi Zoccai, Giuseppe ^a,b   Landoni, Giovanni ^c,d   Carnevale, Roberto ^a,b   Cavarretta, Elena ^a,b   Sciarretta, Sebastiano ^a,e   Frati, Giacomo ^a,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Mediterranea Cardio Center   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANAKINRA; ANGIOTENSIN CONVERTING ENZYME 2; BARICITINIB; CHLOROQUINE; FEDRATINIB; LOPINAVIR PLUS RITONAVIR; PEPTIDES AND PROTEINS; REMDESIVIR; RUXOLITINIB; TRANSMEMBRANE PROTEASE SERINE 2; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ASYMPTOMATIC DISEASE; CARDIOLOGIST; CORONAVIRUS DISEASE 2019; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DYSPNEA; EXTRACORPOREAL OXYGENATION; FATIGUE; FEVER; HUMAN; LYMPHOCYTE COUNT; MULTIPLE ORGAN FAILURE; MYALGIA; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PANDEMIC; PNEUMONIA; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SORE THROAT; BETACORONAVIRUS; CARDIOLOGY; CORONAVIRUS INFECTION; PROFESSIONAL PRACTICE; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CARDIOLOGY; CORONAVIRUS INFECTIONS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; PROFESSIONAL PRACTICE;

EID: 85082689667     PISSN: 00264725     EISSN: 18271618     Source Type: Journal    
DOI: 10.23736/S0026-4725.20.05250-0     Document Type: Review

References (28)

1. Fauci AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharted. N engl J Med 2020;382:1268–9.
2. Day M. Covid-19: surge in cases in italy and South Korea makes pandemic look more likely. BMJ 2020;368:m751.
3. Peckham R. COVID-19 and the anti-lessons of history. lancet 2020;395:850–2.
4. del rio C, Malani PN. COVID-19-New insights on a rapidly Changing epidemic. JaMa 2020.[epub ahead of print]
5. HAN Q, LIN Q, JIN S, YOU L. recent insights into 2019-nCoV: a brief but comprehensive review. J infect 2020.
6. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health organization declares global emergency: a review of the 2019 novel coronavirus (CoVid-19). int J Surg 2020;76:71–6.
7. Società Italiana Di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) - raccomandazioni di etica clinica per l’ammissione a trattamenti intensivi e per la loro sospensione, in condizioni eccezionali di squilibrio tra necessità e risorse disponibili; [internet] available from: http://www.siaarti.it/News/CoVid19%20-%20documenti%20SiaarTi. aspx [cited 2020, Mar 8].
8. American College of Cardiology (ACC) Clinical Bulletin - COVID-19 Clinical guidanceFor the CVCare Team. [internet] available from: https://www.acc.org//~/media/NonClinical/Files-PdFs-excel-MS-Word-etc/2020/02/S20028-aCC-Clinical-Bulletin-Coronavirus.pdf [cited 2020, Mar 8].
9. Saglietto A, D’Ascenzo F, Zoccai GB, De Ferrari GM. COVID-19 in europe: the italian lesson. lancet 2020;395:1110–1.
10. Patlas MN. COVID-19: What Can We learn From Stories FromtheTrenches?CanassocradiolJ2020:846537120913497.
11. Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 - Studies Needed. N engl J Med 2020;382:1194–6.
12. Gurwitz D. Angiotensin receptor blockers as tentative SarS-CoV-2 therapeutics. drug dev res 2020. [epub ahead of print]
13. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, erichsen S, et al. SarS-CoV-2 Cell entry depends on aCe2 and TMPrSS2 and is Blocked by a Clinically Proven Protease inhibitor. Cell 2020;S0092-8674(20)30229-4.
14. Wu Z, Mcgoogan JM. Characteristics of and important lessons From the Coronavirus disease 2019 (CoVid-19) outbreak in China: Summary of a report of 72 314 Cases From the Chinese Center for disease Control and Prevention. JaMa 2020. [epub ahead of print]
15. ONG SW, TAN YK, CHIA PY, LEE TH, NG OT, WONG MS, et al. air, Surface environmental, and Personal Protective equipment Contamination by Severe acute respiratory Syndrome Coronavirus 2 (SarS-CoV-2) From a Symptomatic Patient. JaMa 2020. [epub ahead of print]
16. LI Q, GUAN X, WU P, WANG X, ZHOU L, TONG Y, et al. early Transmission dynamics in Wuhan, China, of Novel Coronavirus-infected Pneumonia. N engl J Med 2020;382:1199–207.
17. HUANG C, WANG Y, LI X, REN L, ZHAO J, HU Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet 2020;395:497–506.
18. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and rT-PCr Testing in Coronavirus disease 2019 (CoVid-19) in China: a report of 1014 Cases. radiology 2020;200642.
19. Young Be, Ong SW, Kalimuddin S, low Jg, Tan SY, loh J, et al.; Singapore 2019 Novel Coronavirus outbreak research Team. epidemiologic Features and Clinical Course of Patients infected With SarS-CoV-2 in Singapore. JaMa 2020. [epub ahead of print]
20. GUAN WJ, NI ZY, HU Y, LIANG WH, OU CQ, HE JX, et al. China Medical Treatment expert group for Covid-19. Clinical Characteristics of Coronavirus disease 2019 in China. N engl J Med 2020. [epub ahead of print]
21. RUAN Q, YANG K, WANG W, JIANG L, SONG J. Clinical predictors of mortality due to CoVid-19 based on an analysis of data of 150 patients from Wuhan, China. intensive Care Med 2020. [epub ahead of print]
22. Quotidianosanità.It: Coronavirus. Iss: “Febbre e affanno sintomi iniziali più comuni per i deceduti positivi al virus”; [internet] available from: http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=82255&fr=n [cited 2020, Mar 9].
23. Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight CoVid-19. int J antimicrob agents 2020 apr;55(4):105932.
24. CHEN L, XIONG J, BAO L, SHI Y. Convalescent plasma as a potential therapy for CoVid-19. lancet infect dis 2020;20:398–400.
25. Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith d, et al. CoVid-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020;20:400–2.
26. Zheng YY, Ma YT, Zhang JY, Xie X. CoVid-19 and the cardiovascular system. Nat rev Cardiol 2020. [epub ahead of print]
27. GOSTIN LO, HODGE JG Jr. US emergency legal responses to Novel Coronavirus: Balancing Public Health and Civil liberties. JaMa 2020. [epub ahead of print]
28. Liberoquotidiano.It. Coronavirus, Ricciardi: “Può espandersi senza resistenze”. i modelli: possibile 1 milione di morti in italia; [internet] available from: https://www.liberoquotidiano.it/news/italia/20895016/coronavirus_ricciardi_modelli_italia_60_per_cento_contagiato_1_milione_ morti.html [cited 2020, Mar 9].